Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» antibody-drug conjugate
antibody-drug conjugate
Five Deaths in Prostate Cancer Trial Send MacroGenics’ Stock Plummeting
BioSpace
Fri, 05/10/24 - 11:16 am
Macrogenics
clinical trials
antibody-drug conjugate
vobramitamab duocarmazine
prostate cancer
patient deaths
Emergence of ADCs as the “hot, new technology”
Pharmaphorum
Thu, 04/25/24 - 11:39 am
antibody-drug conjugate
Immunogen
AbbVie
Seagen
Pfizer
cancer
M&A
Merck Paid $208 Million to Stop Its Drugs From Working
Motley Fool
Sun, 04/14/24 - 01:27 pm
Merck
M&A
Abceutics
antibody-drug conjugate
AACR: Merck, Kelun’s Anti-TROP2 ADC Shows Early Promise in Gastric Cancer
BioSpace
Wed, 04/10/24 - 09:59 am
Merck
Kelun-Biotech
SKB264
gastric cancer
antibody-drug conjugate
clinical trials
AACR
Bristol Myers-backed TORL secures $158M to march army of ADCs through clinic
Fierce Biotech
Wed, 04/10/24 - 09:52 am
Bristol Myers Squibb
TORL BioTherapeutics
antibody-drug conjugate
funding
The Next Wave of ADCs Could Treat Evasive Solid Tumors
BioSpace
Mon, 04/8/24 - 11:57 am
antibody-drug conjugate
AACR
solid tumors
Elevation Oncology
Tubulis
Prostate cancer ADC acquired from Fortis breaks FibroGen's clinical losing streak
Fierce Biotech
Thu, 04/4/24 - 10:51 am
FibroGen
antibody-drug conjugate
prostate cancer
FG-3246
Genmab leans into hot ADC space with $1.8B ProfoundBio acquisition
BioSpace
Wed, 04/3/24 - 11:38 am
Genmab
M&A
ProfoundBio
antibody-drug conjugate
Ipsen joins ADC race via $900M biobuck deal with Sutro, chasing same target as Merck, Boehringer
Fierce Biotech
Tue, 04/2/24 - 11:34 am
Ipsen
antibody-drug conjugate
Sutro BioPharma
Biotheus, Hansoh Expand Partnership in $694M ADC Deal
BioSpace
Sun, 03/17/24 - 09:20 pm
Biotheus
Hansoh
antibody-drug conjugate
oncology
inflammatory diseases
ADC Biotech Tubulis Closes Upsized $138M Financing Round
BioSpace
Thu, 03/14/24 - 06:16 pm
Tubulis
funding
antibody-drug conjugate
GSK Advances Blenrep’s Potential Comeback with Second Phase III Win
BioSpace
Thu, 03/7/24 - 05:32 pm
GSK
Blenrep
antibody-drug conjugate
clinial trials
Zymeworks halts plans for phase 2 ADC trial to mull 'evolving clinical landscape'
Fierce Biotech
Thu, 03/7/24 - 11:37 am
antibody-drug conjugate
clinical trials
Zymeworks
zanidatamab
ADC Market Will Remain Hot in Oncology, Reaching $30B by 2028: Report
BioSpace
Fri, 03/1/24 - 11:52 am
oncology
cancer
antibody-drug conjugate
Merck
AbbVie
Pfizer
AstraZeneca
Pfizer fleshes out oncology strategy, targeting 8 blockbuster cancer drugs by 2030
Fierce Pharma
Thu, 02/29/24 - 07:05 pm
Pfizer
oncology
Pharma CEOs
Albert Bourla
antibody-drug conjugate
ProfoundBio secures $112m to advance ADC portfolio for cancer
Pharmaceutical Business Review
Wed, 02/14/24 - 10:52 am
ProfoundBio
funding
cancer
antibody-drug conjugate
AstraZeneca, Daiichi aim for first pan-tumor ADC approval
BioPharma Dive
Mon, 01/29/24 - 11:25 am
AstraZeneca
Daiichi Sankyo
antibody-drug conjugate
Enhertu
pan-tumor
FDA
Gilead's Trodelvy fails to extend survival in lung cancer study, prompting selloff
Fierce Pharma
Mon, 01/22/24 - 11:21 am
Gilead Sciences
antibody-drug conjugate
Trodelvy
lung cancer
clinical trials
LegoChem, riding ADC sugar rush, raises $411M from confectionery company
Fierce Biotech
Tue, 01/16/24 - 09:37 am
LegoChem Biosciences
JNJ
antibody-drug conjugate
JPM24: Even after Seagen buyout, Pfizer oncology chief still eyes ADC deals
Fierce Pharma
Thu, 01/11/24 - 11:34 am
Pfizer
oncology
cancer
antibody-drug conjugate
JPMHC 2024
Pages
1
2
3
4
5
6
7
8
9
next ›
last »